print

Financial performance analysis of pharmaceutical companies listed on the Indonesia Stock Exchange (IDX) before and after the national healthcare insurance coverage (JKN-Jaminan Kesehatan Nasional) program by BPJS Kesehatan

---

The research analyses Pharmaceutical Company’s Financial Performance on the selected companies focusing on Sales Contribution Sales from the JKN Program and Return on Equity. The National Healthcare Insurance Coverage or JKN – Jaminan Kesehatan Nasional is an Indonesian healthcare reform program with aim to reach Universal Health Coverage launched on January 1st2014. Furthermore this research objectives is to reveal the significant changes of company’s Net Sales the year before and the year after application of the program with additional aim to find the correlation between selected Financial Performance Variables which gathered from Annual Report by using Paired Sample T-Test on SPSS Program.rnrnThe results are

---

Availability

B02205

2205

(Rack Thesis)

Available

Detail Information

Series Title

-

Call Number

2205

Publisher

mou : Swiss German University., 2016

Collation

-

Language

English

ISBN/ISSN

-

Classification

NONE

Content Type

-

Media Type

-

Carrier Type

-

Edition

-

Subject(s)

-

Specific Detail Info

-

Statement of Responsibility

negative correlation between percentage sales contribution from companies and Net Sales growth rate

Other version/related

File Attachment

Comments

---

You must be logged in to post a comment